|
2024
|
Invention
|
Stabilized trimeric rsv fusion proteins without a heterologous trimerzation domain. The present i... |
|
2023
|
Invention
|
Influenza b virus vaccines and uses thereof. Provided herein are isolated mutant influenza hemagg... |
|
|
Invention
|
Stabilized pre-fusion piv3 f proteins. The present invention relates to stabilized pre-fusion hum... |
|
|
Invention
|
Stabilized trimeric class i fusion proteins. The present invention relates to trimeric class I fu... |
|
|
Invention
|
Pre-fusion human piv1 f proteins. The present invention relates to stabilized human parainfluenza... |
|
|
Invention
|
Stabilized coronavirus s proteins. The present invention relates to stabilized HCoV-NL63 S protei... |
|
|
Invention
|
Rsv immunogens. The present invention relates to immunogens comprising at least one recombinant R... |
|
|
Invention
|
Trimer stabilizing hiv envelope protein mutations.
Human immunodeficiency virus (HIV) envelope p... |
|
|
Invention
|
Compositions and methods for the diagnosis of hiv infection. The invention provides compositions ... |
|
|
Invention
|
Stabilized pre-fusion hmpv fusion proteins. The present invention relates to stabilized pre-fusio... |
|
|
Invention
|
Sequential administration of adenoviruses. Provided are methods for inducing an immune response a... |
|
|
Invention
|
Trimer stabilizing hiv envelope protein mutations r304v, n302m and t320l. The invention relates t... |
|
2022
|
Invention
|
Potent and balanced bidirectional promoter.
The invention provides a bidirectional hCMV-CAG4 pro... |
|
|
Invention
|
Stabilized soluble pre-fusion rsv f polypeptides.
Described are stable pre-fusion respiratory sy... |
|
|
Invention
|
Influenza virus vaccines and uses thereof. Provided herein are influenza hemagglutinin stem polyp... |
|
|
Invention
|
Combinations of vaccines and neutralizing antibodies for treating human immunodeficiency virus in... |
|
|
Invention
|
Trimer stabilizing hiv envelope protein mutations. Human immunodeficiency virus (HIV) envelope pr... |
|
|
Invention
|
Human spermine oxidase crystal and uses thereof. A human spermine oxidase polypeptide comprises a... |
|
|
Invention
|
Vaccine against rsv. The present invention relates to novel nucleic acid molecules encoding a pre... |
|
|
Invention
|
Calibration of elisa for clinical antibody response by quantitative mass spectrometry.
Methods o... |
|
|
Invention
|
Calibration of elisa for clinical antibody response by quantitative mass spectrometry. Methods of... |
|
|
Invention
|
Trimer stabilizing hiv envelope protein mutation. Human immunodeficiency virus (HIV) envelope pro... |
|
|
Invention
|
Trimer stabilizing hiv envelope protein mutation.
Human immunodeficiency virus (HIV) envelope pr... |
|
|
Invention
|
Stabilized pre-fusion rsv fb antigens.
The present invention provides stable pre-fusion respirat... |
|
|
Invention
|
Vaccine combinations against respiratory syncytial virus strain a and b infections. Methods of sa... |
|
|
Invention
|
Stabilized pre-fusion rsv fb antigens. The present invention provides stable pre-fusion respirato... |
|
|
Invention
|
B antigens. BB proteins, nucleic acid molecules and vectors encoding such proteins, and compositi... |
|
|
Invention
|
Method for the safe induction of immunity against rsv.
Methods of inducing a safe immune respons... |
|
|
Invention
|
Methods and compositions for inducing protective immunity against rsv infection.
Compositions, v... |
|
|
Invention
|
Vaccine against rsv. Compositions including a recombinant respiratory syncytial virus (RSV) Fusio... |
|
2021
|
Invention
|
Cooling element, shipping box with a cooling element, method for temperature stabilisation, and u... |
|
|
Invention
|
Hiv vaccine regimens. Methods are described for generating an improved effective immune response ... |
|
|
Invention
|
Vaccine combination against repiratory syncytial virus infection.
Methods of safely inducing a p... |
|
|
Invention
|
Stabilized vaccine compositions.
The present invention relates to vaccine composition comprising... |
|
2020
|
Invention
|
Vaccine product.
The present invention provides a vaccine product comprising a container, wherei... |
|
|
Invention
|
Influenza virus vaccines and uses thereof.
Provided herein are isolated mutant influenza hemaggl... |
|
|
Invention
|
Adenovirus vectors and uses thereof.
Provided herein are chimeric adenoviral vectors. The provid... |
|
|
Invention
|
Staphylococcus peptides and methods of use.
Provided herein are immunogenic compositions compris... |
|
|
Invention
|
Influenza virus vaccines and uses thereof.
Provided herein are group 2 influenza hemagglutinin s... |
|
|
Invention
|
Co-administration of seasonal influenza vaccine and an adenovirus based respiratory syncytial vir... |
|
|
Invention
|
Prophylactic treatment of respiratory syncytial virus infection with an adenovirus based vaccine.... |
|
|
Invention
|
Methods for inducing a safe immune response against polio virus.
The present invention relates t... |
|
|
Invention
|
Recombinant influenza antigens.
The invention provides recombinant influenza A hemagglutinin (HA... |
|
2008
|
P/S
|
Media (growth media) for growing cells and cell lines. |
|
|
P/S
|
Chemically defined media and media supplements for the growth of mammalian cells in culture |
|
2006
|
P/S
|
Live cells and cell-lines; media (culture broth) for the cultivation of cells and cell-lines; gen... |
|
2005
|
P/S
|
Genetically modified viral material, namely, nucleic encoding viruses, viral particles and viral ... |
|
2004
|
P/S
|
Living cells and cell lines; growth media (cultures) for the
cultivation of cells and cell lines... |
|
2000
|
P/S
|
[ Genetic modified cells and cell lines, viruses, polynucleic acids, polynucleotides, proteins, p... |
|
|
P/S
|
Cells and cell-lines for scientific, laboratory or medical research and for the use in the manufa... |
|
1999
|
P/S
|
Genetically modified material for use in the preparation of pharmaceutical products and for resea... |
|
1998
|
P/S
|
Live cells and cell-lines; media (culture broths) for the cultivation of cells and cell-lines; mo... |
|
|
P/S
|
Live cells and cell-lines; media (culture brothd) for the cultivation of cells and cell-lines; ge... |
|
1997
|
P/S
|
Biochemicals in the field of genetic pharmacology; namely, genetic materials for use in connectio... |
